Evaluation of pediatric malignancies using total-body PET/CT with half-dose [18F]-FDG
- PMID: 35788704
- DOI: 10.1007/s00259-022-05893-8
Evaluation of pediatric malignancies using total-body PET/CT with half-dose [18F]-FDG
Abstract
Purpose: To explore the impact of a true half dose of [18F]-FDG on image quality in pediatric oncological patients undergoing total-body PET/CT and investigate short acquisition times with half-dose injected activity.
Methods: One hundred pediatric oncological patients who underwent total-body PET/CT using the uEXPLORER scanner after receiving a true half dose of [18F]-FDG (1.85 MBq/kg) were retrospectively enrolled. The PET images were first reconstructed using complete 600-s data and then split into 300-s, 180-s, 60-s, 40-s, and 20-s duration groups (G600 to G20). The subjective analysis was performed using 5-point Likert scales. Objective quantitative metrics included the maximum standard uptake value (SUVmax), SUVmean, standard deviation (SD), signal-to-noise ratio (SNR), and SNRnorm of the background. The variabilities in lesion SUVmean, SUVmax, and tumor-to-background ratio (TBR) were also calculated.
Results: The overall image quality scores in the G600, G300, G180, and G60 groups were 4.9 ± 0.2, 4.9 ± 0.3, 4.4 ± 0.5, and 3.5 ± 0.5 points, respectively. All the lesions identified in the half-dose images were localized in the G60 images, while 56% of the lesions could be clearly identified in the G20 images. With reduced acquisition time, the SUVmax and SD of the backgrounds were gradually increased, while the TBR values showed no statistically significant differences among the groups (all p > 0.1). Using the half-dose images as a reference, the variability in the lesion SUVmax gradually increased from the G180 to G20 images, while the lesion SUVmean remained stable across all age groups. SNRnorm was highly negatively correlated with age.
Conclusion: Total-body PET/CT with a half dose of [18F]-FDG (1.85 MBq/kg, estimated whole-body effective dose: 1.76-2.57 mSv) achieved good performance in pediatric patients, with sufficient image quality and good lesion conspicuity. Sufficient image quality and lesion conspicuity could be maintained at a fast scanning time of 60 s with half-dose activity.
Keywords: Low dose; Pediatric; Total-body PET/CT; [18F]-FDG.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Boellaard RD-BR, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. European Association of Nuclear Medicine (EANM). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:28–54. https://doi.org/10.1007/s00259-014-2961-x . - DOI
-
- Fahey FHTS, Adelstein SJ. Minimizing and communicating radiation risk in pediatric nuclear medicine. J Nucl Med. 2011;52:1240–51. https://doi.org/10.2967/jnumed.109.069609 . - DOI - PubMed
-
- Ricard F, Cimarelli S, Deshayes E, Mognetti T, Thiesse P, Giammarile F. Additional benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma. Clin Nucl Med. 2011;36:672–7. https://doi.org/10.1097/RLU.0b013e318217ae2e . - DOI - PubMed
-
- Fahey FH, Goodkind A, MacDougall RD, Oberg L, Ziniel SI, Cappock R, et al. Operational and dosimetric aspects of pediatric PET/CT. J Nucl Med. 2017;58:1360–6. https://doi.org/10.2967/jnumed.116.182899 . - DOI - PubMed - PMC
-
- Turpin S, Martineau P, Levasseur MA, Meijer I, Décarie JC, Barsalou J, et al. 18F-Flurodeoxyglucose positron emission tomography with computed tomography (FDG PET/CT) findings in children with encephalitis and comparison to conventional imaging. Eur J Nucl Med Mol Imaging. 2019;46:1309–24. https://doi.org/10.1007/s00259-019-04302-x . - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
